End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,530 KRW | +0.15% |
|
+3.16% | -34.04% |
Chart calendar Genexine, Inc.
Upcoming events on Genexine, Inc.
Past events on Genexine, Inc.
2024-03-27 | Shareholders Meeting |
2024-03-12 | Q4 2023 Earnings Release |
2023-11-13 | Q3 2023 Earnings Release |
2023-06-05 14:15 | American Society of Clinical Oncology Conference - Abstract No 6075 |
2023-05-14 | Q1 2023 Earnings Release |
2023-03-19 | Q4 2022 Earnings Release |
2023-02-05 | BIO CEO & Investor Conference |
2023-01-08 | JP Morgan Healthcare Conference |
2022-11-13 | Q3 2022 Earnings Release |
2022-09-10 02:35 | European Society for Medical Oncology Congress |
2022-08-15 | Interim 2022 Earnings Release |
2022-05-24 07:00 | H.C. Wainwright Global Investment Conference |
2022-05-15 | Q1 2022 Earnings Release |
2021-08-16 | Interim 2021 Earnings Release |
2021-05-16 | Q1 2021 Earnings Release |
2021-03-18 | FY 2020 Earnings Release |
2020-03-29 | FY 2019 Earnings Release |
2019-11-13 | Q3 2019 Earnings Release |
2019-09-08 | Morgan Stanley Global Health Care Conference |
2019-05-13 | Q1 2019 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 11,3 16,0 -29.39% | 18,5 18,4 0.6% | 0,00 | 0,47 | 3,87 |
EBITDA Billions KRW | Released Forecast Spread | -42,0 -33,8 -24.51% | -36,2 -31,1 -16.55% | 0,00 | 0,00 | 0,00 |
EBIT Billions KRW | Released Forecast Spread | -44,5 -36,9 -20.53% | -39,2 -35,2 -11.31% | 0,00 | -10,6 | -40,5 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,00 0,00 - | 27,5 -43,4 163.45% | 0,00 | -16,9 | -39,1 |
Net income Billions KRW | Released Forecast Spread | 0,00 0,00 - | 27,6 -43,4 163.52% | -47,7 | -16,9 | -39,1 |
EPS KRW | Released Forecast Spread | 0,00 0,00 - | 672 -1 402 147.89% | -1 473 | -443 | -967 |
Announcement Date | 04/03/20 | 12/03/21 | 17/03/22 | 15/05/23 | 13/03/24 |
Quarterly results
Fiscal Period | December | 2023 Q3 |
---|---|---|
Net sales Billions KRW | Released Forecast Spread | 0,36 |
Announcement Date | 15/11/23 |
Past sector events for Genexine, Inc.
2024-06-05 03:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A095700 Stock
- Calendar Genexine, Inc.